Literature DB >> 8555713

Characteristics of the eating disorder in Prader-Willi syndrome: implications for treatment.

A J Holland1, J Treasure, P Coskeran, J Dallow.   

Abstract

Over-eating and resultant obesity is well recognized as a central feature of the Prader-Willi Syndrome (PWS). The eating behaviour of 13 subjects with PWS was been studied retrospectively over a 28-day period and also by direct observation when given free access to food. Changing cognitions normally associated with food intake (e.g. changes in hunger) were assessed using visual analogue scales (VAS) and by asking subjects to rate photographs of particular foods. Eight out of 13 subjects (61%) with PWS had to have their access to food severely restricted. Ten (77%) ate excessive amounts when given free access to food, and although feelings of 'hunger', 'desire to eat' and 'fullness' changed in the expected direction, these changes were delayed, compared to a control group, and only occurred after eating a significantly greater amount of food. Ratings of 'hunger' and 'fullness' started to return to pre-meal levels sooner than in the controls. The present authors consider that PWS is an example of genetic obesity secondary to an impaired satiety response. These observations have important implications for treatment.

Entities:  

Mesh:

Year:  1995        PMID: 8555713     DOI: 10.1111/j.1365-2788.1995.tb00541.x

Source DB:  PubMed          Journal:  J Intellect Disabil Res        ISSN: 0964-2633


  18 in total

1.  Metformin therapy for diabetes in Prader-Willi syndrome.

Authors:  N N Chan; M D Feher; N A Bridges
Journal:  J R Soc Med       Date:  1998-11       Impact factor: 5.344

2.  Changes in appetite, food preference, and eating habits in frontotemporal dementia and Alzheimer's disease.

Authors:  M Ikeda; J Brown; A J Holland; R Fukuhara; J R Hodges
Journal:  J Neurol Neurosurg Psychiatry       Date:  2002-10       Impact factor: 10.154

3.  Genetically determined obesity in Prader-Willi syndrome: the ethics and legality of treatment.

Authors:  A J Holland; J Wong
Journal:  J Med Ethics       Date:  1999-06       Impact factor: 2.903

4.  Eye tracking as an objective measure of hyperphagia in children with Prader-Willi syndrome.

Authors:  Alexandra P Key; Hatun Zengin-Bolatkale; Anastasia Dimitropoulos; Ellen Doernberg
Journal:  Am J Med Genet A       Date:  2020-04-28       Impact factor: 2.802

5.  Plasma cholecystokinin levels in Prader-Willi syndrome and obese subjects.

Authors:  M G Butler; M G Carlson; D E Schmidt; I D Feurer; T Thompson
Journal:  Am J Med Genet       Date:  2000-11-06

6.  Systematic review of the clinical and genetic aspects of Prader-Willi syndrome.

Authors:  Dong Kyu Jin
Journal:  Korean J Pediatr       Date:  2011-02-28

7.  A measure of food seeking in individuals with Prader-Willi syndrome.

Authors:  J Young; J Zarcone; L Holsen; M C Anderson; S Hall; D Richman; M G Butler; T Thompson
Journal:  J Intellect Disabil Res       Date:  2006-01

8.  Prader-Willi syndrome.

Authors:  Suzanne B Cassidy; Daniel J Driscoll
Journal:  Eur J Hum Genet       Date:  2008-09-10       Impact factor: 4.246

9.  Life Satisfaction Among Mothers of Individuals with Prader-Willi Syndrome.

Authors:  Carolyn M Shivers; Caroline L Leonczyk; Elisabeth M Dykens
Journal:  J Autism Dev Disord       Date:  2016-06

10.  Eye Tracking as a Marker of Hyperphagia in Prader-Willi Syndrome.

Authors:  Alexandra P Key; Elisabeth M Dykens
Journal:  Dev Neuropsychol       Date:  2018-02-07       Impact factor: 2.253

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.